Data from Bangalore, India-based Tracxn Technologies shows venture capital investment in home-grown health-tech startups in 2018 is at an all-time high. With continuing investor interest, so far $510 million has been invested across eighty health-tech startups.
These investments were led by medicine ordering website PharmEasy, which raised $115 million across three rounds this year. Other significant funding rounds include fitness startup Curefit raising $100 million from San Francisco, CA-based IDG Ventures, and online pharmacy Netmeds securing a $35 million round led by Cambodian investor DPC Group.
According to investors, increased funding in health-tech startups is due to factors such as increased internet penetration, rise in digital payments, and big-ticket government initiatives such as Ayushman Bharat. “Healthcare is also an acutely understood issue in India today, and enabling it with technology is very important. Start-ups, as well as investors, understand that,” said Anup Jain, managing partner of Mumbai-based Orios Venture Partners that participated in a $30-million funding round in PharmEasy in which it had already invested twice earlier.
Amit Varma, founder and managing partner of Singapore-based Quadria Capital, a healthcare-focused private equity fund said, “Start-ups are trying to solve the key issue of last-mile connectivity. No one wants to go 250 miles for better healthcare. And in this, technology is the differentiator.”
Last updated: December 26th, 2025
